ciprofloxacin
- Product NDC
- 68071-4672
- 11-digit product format
- 680714672
- Labeler code
- 68071
- Product ID
- 68071-4672_1ab88258-a402-2353-e063-6394a90a5eca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ciprofloxacin
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA077568
- Marketing category
- ANDA
- Marketing start
- 2018-11-01
- Substance
- CIPROFLOXACIN HYDROCHLORIDE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ciprofloxacin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CIPROFLOXACIN HYDROCHLORIDE | 3 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 4BA73M5E37 |
| Rxcui | 309307 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a21a21e5-f36d-4c1f-8918-def921b8f7e3 | Product name | 3 | 20250124 |
| ea50b939-d92a-4100-84f5-1c1089663837 | Product name | 2 | 20240705 |
| 90aab9f8-63f3-478d-8db8-951525a18ab1 | Product name | 1 | 20180814 |
| 200e1d3d-46da-4371-beed-747da3cb3ff8 | Product name | 1 | 20180702 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| 9e453f34-aacb-44d5-a119-c0e3dc1fca2a | Product name | 1 | 20160622 |
| 01eecbfe-0b50-413b-8898-6905c89b6568 | Product name | 1 | 20151228 |
| a3304bb6-ef4e-06df-d604-35f7e883ed6c | Product name | 1 | 20140508 |
| abaf203f-619e-f265-559f-8c81af5cb1c2 | Product name | 1 | 20140508 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
| de5ea793-ffd9-0308-b0ca-00d9967be4ee | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4672-3 | 2024-06-12 | C162847 | 48780-1 | ba0f9c33-1b2f-a910-e053-dadaa90a0b85 | Ciprofloxacin ophthalmic solution USP 0.3% as base Sterile |
| 68071-4672-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-1b2f-a910-e053-dadaa90a0b85 | Ciprofloxacin ophthalmic solution USP 0.3% as base Sterile |
| 68071-4672-3 | 2021-02-17 | C162847 | 48780-1 | ba0f9c33-1b2f-a910-e053-dadaa90a0b85 | Ciprofloxacin ophthalmic solution USP 0.3% as base Sterile |
| 68071-4672-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1b2f-a910-e053-dadaa90a0b85 | Ciprofloxacin ophthalmic solution USP 0.3% as base Sterile |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4672-3 | ciprofloxacin | 2.5 mL in 1 BOTTLE | SOLUTION | 2.5 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4672 | CIPROFLOXACIN SOLUTION [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240614_7d533171-0879-3854-e053-2a91aa0a3b46.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 309307 | ciprofloxacin HCl 0.3 % Ophthalmic Solution | PSN | 7d533171-0879-3854-e053-2a91aa0a3b46 | 4 |
| 309307 | ciprofloxacin 3 MG/ML Ophthalmic Solution | SCD | 7d533171-0879-3854-e053-2a91aa0a3b46 | 4 |
| 309307 | ciprofloxacin 0.3 % Ophthalmic Solution | SY | 7d533171-0879-3854-e053-2a91aa0a3b46 | 4 |
| 309307 | ciprofloxacin 3 MG/ML (as ciprofloxacin hydrochloride 3.5 MG/ML) Ophthalmic Solution | SY | 7d533171-0879-3854-e053-2a91aa0a3b46 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-4672-3 | 68071467203 | 2.5 mL in 1 BOTTLE (68071-4672-3) | 2.5 ml | 2018-12-18 | 0000-00-00 | No | No | Current |